1. Home
  2. INVE vs GNLX Comparison

INVE vs GNLX Comparison

Compare INVE & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Identiv Inc.

INVE

Identiv Inc.

HOLD

Current Price

$3.98

Market Cap

115.7M

Sector

Technology

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.97

Market Cap

132.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INVE
GNLX
Founded
1990
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.7M
132.7M
IPO Year
1997
2022

Fundamental Metrics

Financial Performance
Metric
INVE
GNLX
Price
$3.98
$2.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$5.50
$17.25
AVG Volume (30 Days)
73.3K
155.6K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
$60,219,000.00
$8,000.00
Revenue This Year
$22.10
N/A
Revenue Next Year
$20.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.21
N/A
52 Week Low
$3.08
$2.29
52 Week High
$5.30
$8.54

Technical Indicators

Market Signals
Indicator
INVE
GNLX
Relative Strength Index (RSI) 47.34 51.84
Support Level $3.14 $2.33
Resistance Level $4.07 $2.97
Average True Range (ATR) 0.17 0.17
MACD -0.00 -0.01
Stochastic Oscillator 33.42 61.46

Price Performance

Historical Comparison
INVE
GNLX

About INVE Identiv Inc.

Identiv Inc develops specialty radio-frequency identification (RFID) and Internet of Things It (IoT) solutions that address customers' challenges and create new opportunities for them through the digitization and enhanced connectivity to the IoT. It designs, produces, and sells RFID and Bluetooth Low Energy (BLE) enabled devices, RFID inlays, tags, and labels that can be applied or incorporated into physical objects, providing them with a digital identity and the ability for customers to track, monitor, authenticate, and engage with consumers. Its IoT Business segment develops, manufactures, and supplies specialty IoT solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: